Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.. Founded in 2018, Monte Rosa Therapeutics is backed by investors that include New Enterprise Associates (NEA) and Versant Ventures and is headquartered in Basel.